Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Groh

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Electrophysiology|October 12, 1999
A transgenic model of myotonic dystrophy: will the mouse roar?W J Groh
The New England Journal of Medicine|September 19, 2000
Cardiopulmonary resuscitation by chest compression aloneW J Groh, D P Zipes
Journal of Cardiovascular Electrophysiology|September 28, 2001
Excessive charge time delaying ventricular tachycardia therapyV R Panchal, W J Groh
The Annals of Thoracic Surgery|June 1, 1994
Bilateral internal mammary-to-pulmonary artery fistulas after a coronary operationW J Groh, H Hovaguimian, M J Morton
Clinical Nephrology|October 6, 2007
A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death riskA N Friedman, W J Groh, M Das
The New England Journal of Medicine|March 10, 2001
Automated external defibrillatorsW J Groh, M E Salive, L D Richardson, et al.
Journal of Cardiovascular Electrophysiology|May 1, 1997
Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongationW J Groh, K J Gibson, J G Maylie
American Family Physician|February 11, 1998
Advances in the treatment of arrhythmias: implantable cardioverter-defibrillatorsW J Groh, L D Foreman, D P Zipes
Cardiovascular Research|February 1, 1996
Hypotonic-induced stretch counteracts the efficacy of the class III antiarrhythmic agent E-4031 in guinea pig myocytesW J Groh, K J Gibson, J G Maylie
Heart (British Cardiac Society)|November 16, 2002
What's bad for the gander...women and sudden cardiac deathW J Groh, E von der Lohe, D P Zipes
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Electrophysiology|October 12, 1999
A transgenic model of myotonic dystrophy: will the mouse roar?W J Groh
The New England Journal of Medicine|September 19, 2000
Cardiopulmonary resuscitation by chest compression aloneW J Groh, D P Zipes
Journal of Cardiovascular Electrophysiology|September 28, 2001
Excessive charge time delaying ventricular tachycardia therapyV R Panchal, W J Groh
The Annals of Thoracic Surgery|June 1, 1994
Bilateral internal mammary-to-pulmonary artery fistulas after a coronary operationW J Groh, H Hovaguimian, M J Morton
Clinical Nephrology|October 6, 2007
A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death riskA N Friedman, W J Groh, M Das
The New England Journal of Medicine|March 10, 2001
Automated external defibrillatorsW J Groh, M E Salive, L D Richardson, et al.
Journal of Cardiovascular Electrophysiology|May 1, 1997
Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongationW J Groh, K J Gibson, J G Maylie
American Family Physician|February 11, 1998
Advances in the treatment of arrhythmias: implantable cardioverter-defibrillatorsW J Groh, L D Foreman, D P Zipes
Cardiovascular Research|February 1, 1996
Hypotonic-induced stretch counteracts the efficacy of the class III antiarrhythmic agent E-4031 in guinea pig myocytesW J Groh, K J Gibson, J G Maylie
Heart (British Cardiac Society)|November 16, 2002
What's bad for the gander...women and sudden cardiac deathW J Groh, E von der Lohe, D P Zipes
Pageof 3